Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORION
NCT00654394Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2000
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of rosuvastatin in hypercholesterolemia, carotid artery stenosis (CAS), sponsored by AstraZeneca. Started Jan 2000; status: completed.
02
Drugs
rosuvastatin
03
Conditions
hypercholesterolemiacarotid artery stenosis (CAS)
Beyond the preview
Go deeper on NCT00654394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00654394.